NASDAQ:MREO | Cash Flow Statement | Mereo BioPharma Group plc

Complete source-backed cash-flow history.

Available history
2022-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$7.01M
2026-03-31-$6.72M-$4.31M$0.00-$300,000.00$0.00
2025-12-31-$7.35M-$7.68M$0.00$0.00$39,000.00
2025-09-30-$7.02M
2025-06-30-$14.62M
2025-03-31-$12.89M-$8.33M$20,000.00-$320,000.00$422,000.00
2024-12-31-$7.05M-$9.42M$0.00$0.00-$40,000.00
2024-09-30-$15M
2024-06-30-$12.26M
2024-03-31-$8.95M-$7.99M$0.00-$700,000.00$0.00
2023-12-31-$9.11M-$6.79M$0.00$0.00
2023-09-30-$6.53M
2023-06-30-$1.75M
2023-03-31-$12.08M-$9.25M-$419,000.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31-$41.88M-$30.97M$20,000.00-$20,000.00$327,000.00
2024-12-31-$43.25M-$32.83M$0.00-$699,000.00$46.15M
2023-12-31-$29.47M-$21.13M$0.00-$419,000.00$7.97M
2022-12-31-$42.22M-$48.82M$13,000.00$1.99M$200,000.00